BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12021274)

  • 21. Hypotensive agents from snake venoms.
    Joseph R; Pahari S; Hodgson WC; Kini RM
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Dec; 4(4):437-59. PubMed ID: 15578962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel svVEGF isoforms from Macrovipera lebetina venom interact with neuropilins.
    Aloui Z; Hoos S; Geretti E; Kharmachi H; Haumont PY; Mejdoub H; Klagsbrun M; England P; Gasmi A
    Biochem Biophys Res Commun; 2009 Nov; 389(1):10-5. PubMed ID: 19695228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation.
    Wu LW; Mayo LD; Dunbar JD; Kessler KM; Baerwald MR; Jaffe EA; Wang D; Warren RS; Donner DB
    J Biol Chem; 2000 Feb; 275(7):5096-103. PubMed ID: 10671553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1.
    Wise LM; Veikkola T; Mercer AA; Savory LJ; Fleming SB; Caesar C; Vitali A; Makinen T; Alitalo K; Stacker SA
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3071-6. PubMed ID: 10077638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1.
    Takahashi H; Hattori S; Iwamatsu A; Takizawa H; Shibuya M
    J Biol Chem; 2004 Oct; 279(44):46304-14. PubMed ID: 15328352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor fails to acutely modulate endothelial permeability during early angiogenesis in the chick chorioallantoic membrane.
    DeFouw LM; DeFouw DO
    Microvasc Res; 2000 Nov; 60(3):212-21. PubMed ID: 11078637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability.
    Spyridopoulos I; Luedemann C; Chen D; Kearney M; Chen D; Murohara T; Principe N; Isner JM; Losordo DW
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):901-6. PubMed ID: 12067896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro.
    Marconcini L; Marchio S; Morbidelli L; Cartocci E; Albini A; Ziche M; Bussolino F; Oliviero S
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9671-6. PubMed ID: 10449752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tranilast inhibits protein kinase C-dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells.
    Koyama S; Takagi H; Otani A; Suzuma K; Nishimura K; Honda Y
    Br J Pharmacol; 1999 May; 127(2):537-45. PubMed ID: 10385256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.
    Witzenbichler B; Asahara T; Murohara T; Silver M; Spyridopoulos I; Magner M; Principe N; Kearney M; Hu JS; Isner JM
    Am J Pathol; 1998 Aug; 153(2):381-94. PubMed ID: 9708799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165.
    Soker S; Gollamudi-Payne S; Fidder H; Charmahelli H; Klagsbrun M
    J Biol Chem; 1997 Dec; 272(50):31582-8. PubMed ID: 9395496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
    Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE
    Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific distribution of VEGF-F in Viperinae snake venoms: isolation and characterization of a VGEF-F from the venom of Daboia russelli siamensis.
    Tokunaga Y; Yamazaki Y; Morita T
    Arch Biochem Biophys; 2005 Jul; 439(2):241-7. PubMed ID: 15992764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity.
    Whittles CE; Pocock TM; Wedge SR; Kendrew J; Hennequin LF; Harper SJ; Bates DO
    Microcirculation; 2002 Dec; 9(6):513-22. PubMed ID: 12483548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
    Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
    Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The adapter protein, Grb10, is a positive regulator of vascular endothelial growth factor signaling.
    Giorgetti-Peraldi S; Murdaca J; Mas JC; Van Obberghen E
    Oncogene; 2001 Jul; 20(30):3959-68. PubMed ID: 11494124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
    Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.
    Murohara T; Horowitz JR; Silver M; Tsurumi Y; Chen D; Sullivan A; Isner JM
    Circulation; 1998 Jan 6-13; 97(1):99-107. PubMed ID: 9443437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via Src dependent pathway in retinal endothelial cells.
    Kalishwaralal K; Sheikpranbabu S; BarathManiKanth S; Haribalaganesh R; Ramkumarpandian S; Gurunathan S
    Angiogenesis; 2011 Mar; 14(1):29-45. PubMed ID: 21061058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.